- Home
- AKTX vs INKT Comparison
AKTX vs INKT Comparison
Compare AKTX & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKTX
- INKT
- Stock Information
- Founded
- AKTX N/A
- INKT 2017
- Country
- AKTX United States
- INKT United States
- Employees
- AKTX N/A
- INKT N/A
- Industry
- AKTX Biotechnology: Pharmaceutical Preparations
- INKT Medicinal Chemicals and Botanical Products
- Sector
- AKTX Health Care
- INKT Health Care
- Exchange
- AKTX Nasdaq
- INKT Nasdaq
- Market Cap
- AKTX 24.5M
- INKT 33.6M
- IPO Year
- AKTX N/A
- INKT 2021
- Fundamental
- Price
- AKTX $1.10
- INKT $9.00
- Analyst Decision
- AKTX
- INKT Strong Buy
- Analyst Count
- AKTX 0
- INKT 2
- Target Price
- AKTX N/A
- INKT $37.50
- AVG Volume (30 Days)
- AKTX 28.7K
- INKT 9.2K
- Earning Date
- AKTX 05-15-2025
- INKT 05-13-2025
- Dividend Yield
- AKTX N/A
- INKT N/A
- EPS Growth
- AKTX N/A
- INKT N/A
- EPS
- AKTX N/A
- INKT N/A
- Revenue
- AKTX N/A
- INKT N/A
- Revenue This Year
- AKTX N/A
- INKT N/A
- Revenue Next Year
- AKTX N/A
- INKT N/A
- P/E Ratio
- AKTX N/A
- INKT N/A
- Revenue Growth
- AKTX N/A
- INKT N/A
- 52 Week Low
- AKTX $0.85
- INKT $4.56
- 52 Week High
- AKTX $4.40
- INKT $19.00
- Technical
- Relative Strength Index (RSI)
- AKTX 45.26
- INKT 52.74
- Support Level
- AKTX $1.26
- INKT $8.54
- Resistance Level
- AKTX $1.28
- INKT $9.67
- Average True Range (ATR)
- AKTX 0.14
- INKT 0.88
- MACD
- AKTX -0.02
- INKT 0.10
- Stochastic Oscillator
- AKTX 21.05
- INKT 64.68
About AKTX Akari Therapeutics plc ADS
Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.